We are live on ! Find out more
GLRA

Gerald L. Ray & Associates Portfolio holdings

AUM $802M
1-Year Est. Return 21.01%
This Fund
S&P 500
This Quarter Est. Return
-1.47%
1 Year Est. Return
+21.01%
3 Year Est. Return
+38.23%
5 Year Est. Return
10 Year Est. Return
AUM
$617M
AUM Growth
-$15.9M
Cap. Flow
+$2.55M
Cap. Flow %
0.41%
Top 10 Hldgs %
29.29%
Holding
317
New
11
Increased
93
Reduced
96
Closed
19

Sector Composition

Rank Sector Weight
1 Healthcare 23.26%
2 Industrials 15.25%
3 Consumer Staples 12.09%
4 Technology 8.47%
5 Financials 8.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BNY
276
Bank of New York Mellon
BNY
$106B
$228K 0.04%
6,200
FFIV icon
277
F5
FFIV
$22.9B
$227K 0.04%
2,140
DST
278
DELISTED
DST Systems Inc.
DST
$226K 0.04%
4,000
HPQ icon
279
HP
HPQ
$24.9B
$223K 0.04%
18,101
-3,425
-16% -$36.6K
NDLS icon
280
Noodles & Co
NDLS
$111M
$221K 0.04%
2,331
-294
-11% -$28.4K
CWEN.A
281
DELISTED
Clearway Energy Class A
CWEN.A
$220K 0.04%
16,200
+250
+2% +$3.1K
MS icon
282
Morgan Stanley
MS
$331B
$220K 0.04%
8,816
DVN icon
283
Devon Energy
DVN
$52.1B
$215K 0.03%
7,822
+500
+7% +$12.2K
WBC
284
DELISTED
WABCO HOLDINGS INC.
WBC
$214K 0.03%
2,000
LYB icon
285
LyondellBasell Industries
LYB
$20B
$210K 0.03%
2,450
PPL
286
PPL Corp
PPL
$26.5B
$209K 0.03%
+5,500
New +$195K
XLB icon
287
State Street Materials Select Sector SPDR ETF
XLB
$8.5B
$205K 0.03%
9,172
-300
-3% -$6.21K
PXD
288
DELISTED
Pioneer Natural Resource Co.
PXD
$204K 0.03%
+1,450
New +$180K
TCRT icon
289
Alaunos Therapeutics
TCRT
$4.59M
$189K 0.03%
170
+21
+14% +$21.5K
MNDT
290
DELISTED
Mandiant, Inc. Common Stock
MNDT
$183K 0.03%
+10,200
New +$166K
CC icon
291
Chemours
CC
$2.5B
$117K 0.02%
16,646
+3,000
+22% +$15.1K
WIN
292
DELISTED
Windstream Holdings Inc
WIN
$116K 0.02%
3,031
ERIC icon
293
Ericsson
ERIC
$32.2B
$101K 0.02%
10,090
FNM
294
DELISTED
FANNIE MAE
FNM
$25K ﹤0.01%
17,800
AVNS
295
DELISTED
Avanos Medical
AVNS
-8,403
Closed -$281K
BHC icon
296
Bausch Health
BHC
$2.58B
-4,005
Closed -$407K
CRM icon
297
Salesforce
CRM
$151B
-2,575
Closed -$202K
FCX icon
298
Freeport-McMoran
FCX
$90B
-14,746
Closed -$100K
FRO icon
299
Frontline
FRO
$8.76B
-4,860
Closed -$73K
FXI icon
300
iShares China Large-Cap ETF
FXI
$4.37B
-6,125
Closed -$216K

Similar funds

Gerald L. Ray & Associates's Q1 2016 Portfolio in Review

As of Q1 2016, Gerald L. Ray & Associates held 317 positions worth $617M, down 2.5% from $633M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Gerald L. Ray & Associates's Q1 2016 filing shows 11 new, 93 increased, 96 reduced and 19 closed positions. Its largest new stake was Genesco: 20,861 shares worth $1.51M. The largest sale was SANDISK CORP, an estimated $3.86M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 26% a quarter earlier, followed by Industrials and Consumer Staples.

  • Gerald L. Ray & Associates's largest Q1 2016 buy was Genesco: 20,861 shares worth $1.51M.
  • Gerald L. Ray & Associates added most to Lowe's Companies in Q1 2016, an estimated $5.45M increase.
  • Gerald L. Ray & Associates's biggest Q1 2016 reduction was SANDISK CORP, cutting an estimated $3.86M.
  • Gerald L. Ray & Associates fully exited Bausch Health in Q1 2016, selling an estimated $407K.
  • Gerald L. Ray & Associates's ten largest holdings make up 29% of its $617M portfolio in Q1 2016.
  • Gerald L. Ray & Associates opened 11 new positions and closed 19 in Q1 2016.
  • Gerald L. Ray & Associates's portfolio value fell 2.5% quarter-over-quarter to $617M.

Based on Gerald L. Ray & Associates's 13F filing for Q1 2016, filed 5 May 2016.